MAP3K7 and diabetes mellitus: Thus, inhibition of TAK-1 seems to decrease the severity and incidence of diabetes in NOD mice at least in part by promoting the levels and actions of the antiinflammatory cytokine AAT and consequently enhancing the survival of β cells.